null - FindTrial

NA - COMPARE

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2018-002542-37-FR

Enrollment

Unknown

Registered

2018-07-24

Start date

2018-11-13

Completion date

Unknown

Last updated

2024-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute gout crisis

Interventions

Trade Name: Midazolam Pharmaceutical Form: Injection Trade Name: Fexofenadin Pharmaceutical Form: Tablet

Eligibility

Inclusion criteria

Inclusion criteria: NA Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) no F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

Measure	Time frame
Main Objective: NA;Secondary Objective: NA;Primary end point(s): NA;Timepoint(s) of evaluation of this end point: LSLV	—

Secondary

Measure	Time frame
Secondary end point(s): NA;Timepoint(s) of evaluation of this end point: LSLV	—

Countries

France

Contacts

Public ContactProject manager

Assistance Publique Hôpitaux de Paris

didier.bouton@aphp.fr3310144841744

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026